High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. Kirkwood JM, Ibrahim JG, Sosman JA, Sondak VK, Agarwala SS, Ernstoff MS, Rao U (2001) J Clin Oncol 19: 2370-80 Promises and challenges of pneumococcal conjugate vaccines for the developing world. Grijalva CG, Edwards KM (2006) Clin Infect Dis 43: 680-2 Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR (2004) Clin Infect Dis 39: 641-8 Changes in Otitis Media Episodes and Pressure Equalization Tube Insertions Among Young Children Following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine: A Birth Cohort-based Study. Wiese AD, Huang X, Yu C, Mitchel EF, Kyaw MH, Griffin MR, Grijalva CG (2019) Clin Infect Dis 69: 2162-2169 To Boost or Not to Boost? Lessons from the Australian Pneumococcal Conjugate Vaccination Program. Wiese AD, Grijalva CG (2020) Clin Infect Dis 70: 2616-2618 Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG (2008) Clin Infect Dis 46: 1664-72 Persistent Sex Disparities in Invasive Pneumococcal Diseases in the Conjugate Vaccine Era. de St Maurice A, Schaffner W, Griffin MR, Halasa N, Grijalva CG (2016) J Infect Dis 214: 792-7 Racial and Regional Differences in Rates of Invasive Pneumococcal Disease. de St Maurice A, Grijalva CG, Fonnesbeck C, Schaffner W, Halasa NB (2015) Pediatrics 136: e1186-94 National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, Edwards KM, Griffin MR (2006) Pediatrics 118: 865-73 Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Poehling KA, Szilagyi PG, Grijalva CG, Martin SW, LaFleur B, Mitchel E, Barth RD, Nuorti JP, Griffin MR (2007) Pediatrics 119: 707-15 Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Wiese AD, Griffin MR, Grijalva CG (2019) Expert Rev Vaccines 18: 327-341 Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee. Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W (2013) Pediatr Infect Dis J 32: 604-9 Bacterial Density, Serotype Distribution and Antibiotic Resistance of Pneumococcal Strains from the Nasopharynx of Peruvian Children Before and After Pneumococcal Conjugate Vaccine 7. Hanke CR, Grijalva CG, Chochua S, Pletz MW, Hornberg C, Edwards KM, Griffin MR, Verastegui H, Gil AI, Lanata CF, Klugman KP, Vidal JE (2016) Pediatr Infect Dis J 35: 432-9 Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage. Creech CB, Johnson BG, Alsentzer AR, Hohenboken M, Edwards KM, Talbot TR (2009) Vaccine 28: 256-60 Recognising pneumonia burden through prevention. Grijalva CG (2009) Vaccine 27 Suppl 3: C6-8 Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era. Wiese AD, Griffin MR, Zhu Y, Mitchel EF, Grijalva CG (2016) Vaccine 34: 6243-6249 A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children. Grijalva CG, Pelton SI (2011) Curr Opin Pediatr 23: 98-104 Panel 6: Vaccines. Pelton SI, Pettigrew MM, Barenkamp SJ, Godfroid F, Grijalva CG, Leach A, Patel J, Murphy TF, Selak S, Bakaletz LO (2013) Otolaryngol Head Neck Surg 148: E90-101
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.